Type 2 & other diabetes

On target? Cardiovascular risk factor patterns in type 1 and type 2 diabetes: real-world attainment of cardiovascular risk factor targets and medication prescriptions

Diabetes Res Clin PractPublished Registry-based cohort study

Authors' conclusion

This study shows the extent to which guideline-recommended cardiovascular risk factor targets are met in children and adults with T1D and T2D, which varies by age group and diabetes type.

Study context

Population
Dutch diabetes outpatients with T1D or T2D, Dutch Pediatric and Adult Registry of Diabetes (DPARD), 2017 to 2024
Participants
81,096 outpatients
Exposure
Children with T1D vs Children with T2D vs Adults with T1D vs Adults with T2D
  • Children with T1Dn = 3,832
  • Children with T2Dn = 145
  • Adults with T1Dn = 35,934
  • Adults with T2Dn = 41,185
Outcome
Attainment of cardiovascular risk targets and medication prescription patterns
Methodological detailsdescriptive, real-world
  • Descriptive
  • Real-world

Main finding

As reported in the abstract

Attainment of guideline-recommended cardiovascular risk factor targets
  • For most cardiovascular risk factors, guideline-recommended targets were met by at least two-thirds of patients; some risk factors had lower attainment in specific subgroups
  • HbA1c was the least frequently reached target

Observational data: associations, not effects.

Further findings

Medication prescription patterns

Most common medications for T1D: fast-acting and long-acting insulins
Most common medications for T2D: biguanides, insulins, sulfonylureas, GLP-1 agonists and SGLT2 inhibitors

Original publication

On target? Cardiovascular risk factor patterns in type 1 and type 2 diabetes: real-world attainment of cardiovascular risk factor targets and medication prescriptions. Diabetes Res Clin Pract. Published 14 July 2026. doi:10.1016/j.diabres.2026.113440

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.